The global Cobalt Market was valued at USD 19,847.8 million...
Read MoreThe global Bioprocessing Analytics Equipment Market was valued at USD 562.8 million in 2025 and is projected to expand at a steady CAGR of 4.8% to reach approximately USD 899.4 million by 2036, driven by growth in biologics, including monoclonal antibodies, vaccines, and cell and gene therapies, regulatory encouragement of process analytical technology (PAT) and quality by design, the shift toward continuous and intensified bioprocessing, and the need for real-time data to improve yields and reduce batch failures. The market encompasses bioprocessing analytics equipment by product type, technology, application, end user, and process stage.
The Bioprocessing Analytics Equipment Market’s steady 4.8% CAGR reflects steady investment in measuring and controlling biologic manufacturing. Analytical instruments monitor cell growth, metabolites, product titer, quality attributes, and impurities from cell culture through purification. Demand is recovering after a post-pandemic slowdown: Sartorius reported that its Bioprocess Solutions division grew 8.1% in constant currencies in the first nine months of 2026, with demand for bioprocess equipment and instruments continuing to recover. CDMOs, cell and gene therapy developers, and vaccine producers are adding capacity, and each new facility requires analytical instruments, sensors, and data systems. Biologics growth and regulatory expectations support demand.
What does bioprocessing analytics measure?
Bioprocessing analytics measure parameters such as cell density and viability, glucose, lactate, and other metabolites, dissolved oxygen and pH, product concentration, glycosylation, aggregates, and host cell proteins. These measurements help manufacturers control processes, ensure product quality, and meet regulatory requirements. Analytics are used in upstream cell culture, downstream purification, and final quality control. Rapid and accurate measurements allow operators to adjust feeding, temperature, and other conditions to maximize yield. Measurements include cell density, metabolites, pH, dissolved oxygen, titer, and product quality attributes.
What is process analytical technology?
Process analytical technology (PAT) uses in-line, on-line, or at-line measurements to monitor and control manufacturing in real time rather than relying only on end-of-batch testing. Regulators encourage PAT as part of quality by design. Tools include spectroscopy probes such as Raman and near-infrared, automated sampling, biosensors, and software for multivariate data analysis. PAT can reduce batch failures and enable real-time release testing in some cases. PAT uses real-time measurements to control processes and ensure product quality.
Why is biologics growth important?
Biologics, including monoclonal antibodies, vaccines, recombinant proteins, and cell and gene therapies, are produced in living systems and are sensitive to process conditions. Their growing share of drug pipelines and sales increases demand for analytical equipment. Biosimilars, which must demonstrate comparability with originator products, also require extensive analytics. Large monoclonal antibody plants run many bioreactors in parallel, each requiring monitoring. Monoclonal antibodies and other biologics require extensive testing during production.
How is demand recovering?
After a period of inventory reduction and lower investment following the COVID-19 pandemic, demand for bioprocess equipment is improving. Sartorius’ CEO said in October 2026 that end markets remain fundamentally healthy and that demand for equipment and instruments continued to recover, while consumables remained a key growth driver. Recovery in equipment demand typically follows customers’ new capacity investments. Customers reduced inventory after the pandemic, and orders have been recovering.
What role does continuous bioprocessing play?
Continuous and intensified processes, such as perfusion cell culture and continuous chromatography, run for longer periods and need constant monitoring to maintain quality. This increases the need for real-time sensors and automated analytics. Continuous processing can reduce facility size and cost. Perfusion processes may run for weeks, requiring reliable long-term sensors. Continuous processes need constant monitoring.
How are cell and gene therapies different?
Cell and gene therapies involve small batches, complex products, and often patient-specific manufacturing. Rapid, small-volume analytics for cell identity, potency, viral vector quality, and contamination are critical. This segment is growing quickly but requires new analytical methods. Potency assays for cell therapies are particularly complex. Small batches and complex products need specialized analytical methods.
How do instruments and software work together?
Analyzers, sensors, chromatography and mass spectrometry systems, and cell counters generate data that must be integrated with process control and manufacturing execution systems. Data analytics and digital twins help optimize processes. Software and data integration are becoming important parts of the market. Integration with laboratory information management systems is increasingly expected. Software integrates data from multiple instruments for analysis and reporting.
Who uses bioprocessing analytics?
Biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), academic and research institutes, and vaccine manufacturers are the main users. CDMOs are increasing capacity to serve smaller biotechs, creating demand for flexible analytics. CDMOs need analytics that work across many different customer processes. Biopharma companies, CDMOs, and research institutions are the main users.
What challenges face the market?
High instrument costs, the need to validate new methods, and regulatory requirements can slow adoption. Tariffs and trade issues affect supply chains, as seen in tariff-related effects on suppliers in 2026. Skilled staff are needed to use advanced analytics. Single-use sensors that fit disposable bioreactors are becoming standard. High instrument costs and validation requirements can slow adoption.
Which bioprocessing analytics equipment market segments are growing fastest?
In-line PAT sensors and spectroscopy; analytics for cell and gene therapies; continuous bioprocessing applications; CDMO end users; and data analytics software are the fastest-growing segments. Raman spectroscopy is one of the most widely adopted in-line technologies. In-line and at-line sensors, PAT software, and analytics for cell and gene therapies are among the fastest-growing segments, supported by the shift to continuous manufacturing and the expansion of CDMO capacity.
Key Players: Sartorius, Thermo Fisher Scientific, Danaher (Cytiva), Merck KGaA (MilliporeSigma), Agilent Technologies, Waters Corporation, Repligen, Mettler-Toledo, Shimadzu, Bruker, Hamilton Company, Endress+Hauser, Roche CustomBiotech, Beckman Coulter, Nova Biomedical
The Bioprocessing Analytics Equipment Market’s steady 4.8% CAGR from USD 562.8 million in 2025 toward approximately USD 899.4 million by 2036 is anchored in biologics growth, PAT adoption, continuous processing, and recovering equipment demand. Suppliers such as Sartorius, Thermo Fisher Scientific, and Danaher (Cytiva) are positioned to benefit. Over the forecast period, in-line analytics and cell and gene therapy tools will grow fastest. Suppliers that combine reliable sensors, single-use compatibility, and data software will gain share as biomanufacturing becomes more digital. Regulatory encouragement of advanced manufacturing will support long-term adoption. Software and data integration will grow in importance. Vendors that offer validated, easy-to-integrate instruments and data platforms will benefit as manufacturers digitize their bioprocesses.
Constancy Researchers is a global market intelligence and strategic advisory firm helping organizations navigate complex markets and make high-impact decisions with confidence. In an environment defined by rapid technological change, shifting demand patterns, and evolving competitive dynamics, we provide clarity where it matters most—at the point of decision-making. By combining deep industry understanding, rigorous analytics, and structured thinking, we enable leadership teams to identify opportunities, mitigate risks, and build strategies that drive sustainable growth.
The global Cobalt Market was valued at USD 19,847.8 million...
Read MoreThe global Magnesium Market was valued at USD 5,985.8 million...
Read MoreThe global Welding Equipment Market was valued at USD 23,514.8...
Read MoreWhatsApp us